BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goh KK, Chen CH, Lane HY. Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment. Int J Mol Sci 2021;22:2146. [PMID: 33670047 DOI: 10.3390/ijms22042146] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Coccia G, La Greca F, Di Luca M, Scheggia D. Dissecting social decision-making: A spotlight on oxytocinergic transmission. Front Mol Neurosci 2022;15:1061934. [PMID: 36618824 DOI: 10.3389/fnmol.2022.1061934] [Reference Citation Analysis]
2 Rizavi HS, Chase KA, Liu C, Gavin H, Rosen C, Xia C, Guidotti A, Sharma RP. Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.1006109] [Reference Citation Analysis]
3 Kuzminova MV, Solokhina TА, Nochevkina AI. Motivation Disorders in Patients with Schizophrenia. Psychiatry 2022;20:65-73. [DOI: 10.30629/2618-6667-2022-20-3-85-97] [Reference Citation Analysis]
4 Mouchlianitis ED, Tracy DK, Wigton R, Vanes LD, Fett AK, Shergill SS. Neuroimaging oxytocin modulation of social reward learning in schizophrenia. BJPsych Open 2022;8:e175. [PMID: 36156189 DOI: 10.1192/bjo.2022.577] [Reference Citation Analysis]
5 Goh KK, Lu ML. Relationship between the domains of theory of mind, social dysfunction, and oxytocin in schizophrenia. J Psychiatr Res 2022;155:420-9. [PMID: 36182771 DOI: 10.1016/j.jpsychires.2022.09.013] [Reference Citation Analysis]
6 Fišar Z. Biological hypotheses, risk factors, and biomarkers of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110626. [PMID: 36055561 DOI: 10.1016/j.pnpbp.2022.110626] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Eghtedarian R, Akbari M, Badrlou E, Mahmud Hussen B, Eslami S, Akhavan-Bahabadi M, Taheri M, Ghafouri-Fard S, Neishabouri SM. Assessment of expression of oxytocin-related lncRNAs in schizophrenia. Eur J Pharmacol 2022;:175205. [PMID: 35987251 DOI: 10.1016/j.ejphar.2022.175205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Savina MA, Sheshenin VS, Pochueva VV. Life-time anxiety disorders in patients with late-onset psychosis. Neurology bulletin 2022;LIV:13-22. [DOI: 10.17816/nb87487] [Reference Citation Analysis]
9 Veselinović T, Neuner I. Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia. CNS Drugs 2022. [PMID: 35831706 DOI: 10.1007/s40263-022-00935-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Florea T, Palimariciuc M, Cristofor AC, Dobrin I, Chiriță R, Bîrsan M, Dobrin RP, Pădurariu M. Oxytocin: Narrative Expert Review of Current Perspectives on the Relationship with Other Neurotransmitters and the Impact on the Main Psychiatric Disorders. Medicina 2022;58:923. [DOI: 10.3390/medicina58070923] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Goh KK, Chen CY, Wu T, Chen C, Lu M. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. IJMS 2022;23:7092. [DOI: 10.3390/ijms23137092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Traina G, Tuszynski JA, Cocchi M. Molecular Insights in Psychiatry. Int J Mol Sci 2022;23:4878. [PMID: 35563268 DOI: 10.3390/ijms23094878] [Reference Citation Analysis]
13 Liu N, Yang H, Han L, Ma M. Oxytocin in Women's Health and Disease. Front Endocrinol (Lausanne) 2022;13:786271. [PMID: 35242106 DOI: 10.3389/fendo.2022.786271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Sanson A, Bosch OJ. Dysfunctions of brain oxytocin signaling: Implications for poor mothering. Neuropharmacology 2022;:109049. [PMID: 35390436 DOI: 10.1016/j.neuropharm.2022.109049] [Reference Citation Analysis]
15 Yoon S, Kim YK. Possible oxytocin-related biomarkers in anxiety and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110531. [PMID: 35150782 DOI: 10.1016/j.pnpbp.2022.110531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Broniarczyk-czarniak M, Szemraj J, Śmigielski J, Gałecki P. The Role of OXT, OXTR, AVP, and AVPR1a Gene Expression in the Course of Schizophrenia. CIMB 2022;44:336-49. [DOI: 10.3390/cimb44010025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]